HONG KONG DRUG LICENSING
Hong Kong Drug Licence FAQs
Search 500 Hong Kong drug licence FAQs on applications, personnel, premises, quality systems, ongoing regulation, renewals and acquisitions.
Information status: The original FAQ material dates from 2025 and is provided for topic-based reference; it does not represent an individual verification of all 500 FAQs against current rules. For application, fee, renewal, change, product or prescription requirements, please refer to the current official forms and guidance.
Official information from the Drug Office Official information from the Chinese Medicines Board
找到 500 条结果，第 25／25 页。每页显示 20 条；无需启用 JavaScript。
Q481 · 申请香港药品进出口许可证需要满足哪些主要条件？独立链接
Under section 20 of the Pharmacy and Poisons Ordinance (Cap. 138), applicants for an import or export licence must hold a valid pharmaceutical licence and ensure that imported or exported medicines comply with Hong Kong’s quality and safety standards. Applicants must submit detailed information about the goods, the import or export destination and intended use, and must also have appropriate storage and transport conditions. The Drug Office, Department of Health will rigorously review the application documents to ensure compliance with the requirements for the regulation of medicines. Rengangyongsheng (Hong Kong) Limited recommends preparing all supporting documents in advance to avoid approval delays due to incomplete information.
Q482 · 跨境电商平台如天猫国际销售药品，香港卖家需要具备哪些资质？独立链接
Hong Kong sellers using cross-border e-commerce platforms such as Tmall Global to sell medicines must hold the relevant Hong Kong pharmaceutical licences and obtain the corresponding import and export licences. Under sections 18 and 20 of the Pharmacy and Poisons Ordinance (Cap. 138), sales of regulated medicines must comply with the applicable requirements and use lawful sales channels. Platforms will also require sellers to provide proof of their qualifications. Rengangyongsheng (Hong Kong) Limited recommends that sellers consult the platform and the Hong Kong Department of Health in advance to ensure that all necessary qualifications are in place and avoid the risks of non-compliant sales.
Q483 · 进出口许可证的申请流程一般需要多长时间？独立链接
According to the requirements of the Drug Office, Department of Health, import and export licence applications generally take around 6 to 8 working days to process after complete information has been submitted. Processing may take longer if information is incomplete or special categories of medicines are involved. Applicants should prepare detailed medicine information, evidence of the purpose of import or export, and the relevant licences in advance. Rengangyongsheng (Hong Kong) Limited recommends starting the application 1 month in advance and maintaining communication with the Department of Health during this period to ensure that any additional information is submitted promptly and business operations are not delayed.
Q484 · 通过京东健康等平台销售香港注册药品，需要办理哪些香港药牌？独立链接
To sell medicines on JD Health in Hong Kong, sellers must hold a Hong Kong pharmaceutical licence and the relevant import and export licences. Under the Pharmacy and Poisons Ordinance (Cap. 138), additional licences are required for prescription medicines or controlled medicines. For non-prescription medicines, sellers must ensure that the medicines are registered in Hong Kong or meet the applicable listing requirements. Rengangyongsheng recommends that sellers identify the appropriate licence category based on the types of medicines they intend to sell and confirm the compliance requirements with the platform, to ensure that their sales activities are lawful and compliant.
Q485 · 香港药品进出口许可证是否支持跨境电商直接使用？独立链接
Hong Kong import and export licences for medicines mainly apply to the import and export trade in physical goods. Cross-border e-commerce involves online transactions and delivery, and must still comply with the relevant medicine sales and advertising regulations. Cross-border e-commerce sellers must ensure that they hold valid pharmaceutical trade and import and export licences, and that the medicines sold meet Hong Kong’s registration and labelling requirements. Rengangyongsheng (Hong Kong) Limited advises that cross-border e-commerce businesses take platform rules and Hong Kong regulations into account and use import and export licences appropriately and compliantly, to avoid compliance risks arising from differences in online sales models.
Q486 · 申请进出口许可证时，是否需要提供药品的注册证明？独立链接
Yes, when applying for a Hong Kong medicine import/export licence, you must submit proof of medicine registration or evidence that the product may lawfully be sold in the importing country. Under section 20 of the Pharmacy and Poisons Ordinance (Cap. 138), the Drug Office, Department of Health requires confirmation that the medicine has a lawful source and meets quality standards. If the medicine is not yet registered in Hong Kong, relevant clinical or quality data must be provided in support of the application. Rengangyongsheng (Hong Kong) Limited recommends preparing a complete set of registration documents in advance to help ensure a smooth assessment.
Q487 · 跨境电商销售中，香港卖家如何确保其药品广告符合本地法规？独立链接
Under section 38 of the Pharmacy and Poisons Ordinance (Cap. 138), advertisements for medicines must not contain false or misleading content or promote unapproved therapeutic claims. Cross-border e-commerce sellers must ensure that all advertising complies with the requirements of the Hong Kong Drug Office and must not directly or indirectly promote prescription medicines to the public. Rengangyongsheng (Hong Kong) Limited recommends that sellers work with a professional compliance team to review advertising content and ensure that promotional copy meets regulatory requirements, avoiding regulatory penalties for non-compliant advertising.
Q488 · 香港药剂业许可证和进出口许可证是否可由同一家公司申请？独立链接
Yes. Under the Pharmacy and Poisons Ordinance (Cap. 138), the pharmaceutical licence and import/export licences may be applied for and held by the same corporate entity. The licence holder must meet the relevant requirements for facilities, personnel qualifications and management, and ensure that the storage, transport and sale of medicines comply with the law. Rengangyongsheng (Hong Kong) Limited recommends that businesses consolidate their application processes and manage compliance centrally, which can help improve operational efficiency and reduce regulatory risks.
Q489 · 跨境电商销售药品时，香港卖家是否需要额外申请网络销售许可？独立链接
Hong Kong legislation does not currently establish a separate licence specifically for online medicine sales. However, under the Pharmacy and Poisons Ordinance (Cap.138), any medicine sales activity must be covered by a valid pharmacy licence and the relevant import and export licences. Online sales are subject to the same regulatory requirements as other sales channels. Rengangyongsheng advises sellers to ensure their existing licences cover all sales channels before undertaking cross-border e-commerce, and to monitor the latest Department of Health policies.
Q490 · 如何处理跨境电商平台要求的香港药品进出口资质审查？独立链接
Cross-border e-commerce platforms generally require sellers to provide Hong Kong pharmaceutical licences and import and export licences as evidence of their legal eligibility to sell medicines. Sellers should prepare all required qualification documents, including pharmaceutical licences, import and export licences and product registration certificates, and proactively cooperate with the platform’s qualification review process. Rengangyongsheng (Hong Kong) Limited recommends establishing a standardised qualification management system to ensure that documents are accurate, valid and updated promptly in response to platform requirements, thereby improving the prospects for successful cooperation and the level of business compliance.
Q491 · 如何区分中成药与健康食品在香港的监管分类？独立链接
In Hong Kong, proprietary Chinese medicines are generally regarded as medicines and are regulated under the Pharmacy and Poisons Ordinance (Cap. 138). They require a pharmaceutical licence and must comply with requirements on medicine safety, ingredients and labelling. Health foods do not fall within the category of medicines and are primarily regulated under the Trade Descriptions Ordinance (Cap. 362) and the Food Safety Ordinance (Cap. 612), with an emphasis on food safety and accurate labelling. If a proprietary Chinese medicine contains medicinal ingredients or makes therapeutic claims, it must go through the pharmaceutical licensing approval process; health foods must not claim to treat or prevent disease. Correct classification helps businesses avoid compliance risks.
Q492 · 跨境销售中成药时，香港药牌的管辖范围具体包括哪些？独立链接
Hong Kong’s pharmaceutical licensing regime covers medicines sold, supplied, distributed or displayed in Hong Kong, including proprietary Chinese medicines. Cross-border sales involve importing products into Hong Kong; the medicines must hold valid Hong Kong pharmaceutical licences and comply with local labelling and safety standards. Sales into the Hong Kong market through online platforms are also regarded as supply in Hong Kong and must be compliant. Rengangyongsheng (Hong Kong) Limited assists clients throughout the process with import permits, pharmaceutical licence applications and subsequent compliance oversight, to support the lawful circulation of proprietary Chinese medicines across borders.
Q493 · 仁港永胜（RGYS）如何支持客户实现跨境医药产品一站式合规服务？独立链接
Drawing on extensive industry experience, Rengangyongsheng (Hong Kong) Limited (RGYS) provides end-to-end compliance services covering product classification assessments, medicine licence applications, import customs clearance and labelling reviews. We understand the complexities of cross-border pharmaceutical products under different regulatory systems and help clients develop compliance strategies to reduce approval times. Our team closely monitors the latest policies issued by the Drug Office, Department of Health, and relevant regulators to ensure that clients’ products meet current requirements, helping them enter the Hong Kong market quickly while reducing legal risks.
Q494 · 在香港，健康食品产品标签需要注意哪些合规要点？独立链接
Health food labels in Hong Kong must comply with the requirements of the Trade Descriptions Ordinance (Cap. 362) and the Food Safety Ordinance (Cap. 612). Labels must clearly state the product name, ingredients, net weight, manufacturer and importer information, storage conditions and expiry date. They must not contain medical claims relating to the treatment, diagnosis or prevention of disease. Where Chinese herbal medicine ingredients are involved, their source and quantity should also be stated. Labels should be in Chinese and English to ensure that consumers understand them. Properly compliant labelling not only meets legal requirements but also enhances consumer confidence.
Q495 · 中成药进口至香港时，必须满足哪些主要合规要求？独立链接
When importing proprietary Chinese medicines into Hong Kong, a valid Hong Kong pharmaceutical licence must be held and the import licence requirements under the Pharmacy and Poisons Ordinance (Cap. 138) must be met. Product ingredients, formulae and pharmacological information must be submitted for review by the Drug Office to ensure that the ingredients are safe and the efficacy claims reasonable. Imports must be declared and undergo health inspection. Labels must state the ingredients, directions for use, contraindications and production batch number in both Chinese and English. Rengangyongsheng (Hong Kong) Limited assists clients in preparing complete documents and coordinating imports and pharmaceutical licence applications to help ensure compliant and prompt release.
Q496 · 近年来香港跨境医药行业有哪些重要趋势值得关注？独立链接
In recent years, Hong Kong’s cross-border pharmaceutical industry has seen trends towards digital transformation, tighter regulation and more diverse market demand. With the rise of e-commerce, regulation of online pharmaceutical sales has tightened, bringing stricter requirements for pharmaceutical licences and labelling. At the same time, increased consumer concern about the quality and safety of proprietary Chinese medicines and health products is driving the development of industry standards. Rengangyongsheng (Hong Kong) Limited closely monitors policy developments and helps clients adapt to digital regulatory requirements, bring products to market compliantly and meet changing market needs.
Q497 · 如何有效区分产品是属于药品还是健康食品类别？独立链接
The key to distinguishing medicines from health foods lies in the product’s claims and ingredients. Medicines usually contain active medicinal ingredients and claim to treat, diagnose or prevent diseases, and are regulated under the Pharmacy and Poisons Ordinance (Cap. 138). Health foods are intended to maintain health or supplement nutrition and must not make claims to treat diseases. Rengangyongsheng (Hong Kong) Limited recommends assessing the product category through ingredient analysis and market positioning, together with guidance from the Drug Office, Department of Health, to ensure that the product is promoted lawfully.
Q498 · 仁港永胜如何协助客户应对香港药品监管的最新变革？独立链接
Rengangyongsheng (Hong Kong) Limited closely monitors the latest regulatory and code of practice updates issued by the Drug Office, Department of Health, and relevant departments, and adjusts compliance strategies in a timely manner. We provide clients with regulatory interpretation, compliance training and application document optimisation to ensure that medicine licence applications and renewals meet current requirements. Through data management and tracking systems, we help clients respond efficiently to regulatory changes, reduce compliance risks and ensure that products can enter and remain in the Hong Kong market.
Q499 · 跨境医药产品在香港申请药牌时，常见的合规难点有哪些？独立链接
Common challenges when applying for licences for cross-border pharmaceutical products include insufficient application documentation (such as missing clinical data or ingredient information), labels and package inserts that do not meet local requirements, complex import licensing procedures and lengthy approval periods. Language requirements, special formulations and ingredient controls also pose challenges. Rengangyongsheng (Hong Kong) Limited helps clients overcome these difficulties and expedite the approval process by clarifying application procedures, pre-screening documentation for completeness and providing local compliance advice.
Q500 · 仁港永胜对中成药及保健品的行业未来发展有哪些见解？独立链接
Rengangyongsheng (Hong Kong) Limited considers that demand for proprietary Chinese medicines and health supplements in the Hong Kong market is growing steadily, with consumers increasingly seeking high quality and safety assurance. In future, the sector will place greater emphasis on scientific validation, standardised manufacturing and digital compliance management. Cross-border trade will benefit from policy optimisation and greater regulatory transparency. We recommend that businesses embrace innovation, strengthen communication with regulators, and improve product quality and compliance systems to address changing market conditions and regulatory requirements and gain a competitive edge.